MEDSCINT and DosimETrICA new partnership for distributing innovative radiotherapy QA solutions in Italy
Quebec (CANADA), September 10th, 2024 – MEDSCINT, a leading provider of scintillation dosimetry solutions for radiation therapy quality assurance (QA), has announced a new distribution partnership with DosimETrICA, a renowned independent supplier of dosimetry tools and consultancy in Radiotherapy, Radiology, and Medical Physics. Under this agreement, DosimETrICA will distribute MEDSCINT’s HYPERSCINT™ solutions for research applications to institutions throughout ITALY.
Now used by nearly 50 leading radiotherapy cancer centers in North America, Europe, Middle East and Asia; the patented HYPERSCINT™ detectors by MEDSCINT have proved their value, revolutionizing the meaning of precision dosimetry for challenging radiotherapy applications, including : small-field dosimetry, real-time adaptive QA (e.g. MR-Linac), and ultra-high dose rate (UHDR or FLASH-RT) protocols. Distinctive features of the HYPERSCINT™ detectors include:
- Fast, accurate and time-resolved dose measurements at multiple locations, simultaneously.
- Water-equivalent design for accurate measurements without perturbation nor correction factors.
- Miniature sensitive volume (as little as 0.1 mm³), providing true sharp spatial resolution.
- Innovative Cherenkov/stem removal technique that ensures reliable angular independence across 4π.
- Linear response across a broad spectrum of dose rates, from out-of-field to ultra-high levels.
- Metal-free detector design that eliminates artifacts in high-strength magnetic fields.
“The Italian medical physics community is at the forefront of innovation, and our collaboration with DosimETrICA is a perfect match as modern radiation therapy techniques get deployed in the region,” says Jonathan Turcotte, Co-founder and Chief Marketing Officer at Medscint.
“Plastic scintillators offer outstanding performance, bringing significant value to our customers in the field of medical physics. We are happy to represent Medscint as they set the standards for this innovative way of dynamically measuring radiation with precision,” explains Nicola Franza, Medical Physicist and Owner of DosimETrICA.
This agreement marks a significant step in providing cutting-edge QA tools to the vibrant Italian radiotherapy research community.
About DosimETrICA
DosimETrICA markets advanced tools for dosimetry and consultancy in Radiotherapy, Radiology, and Medical Physics, emphasizing an ethical approach that ensures patient care quality, cost-effectiveness, and safety through cutting-edge technology and shared expertise between providers and users. For more information, please visit www.dosimetrica.com. Media contact: DosimETrICA, Via Siniscalchi 44, 84014 Nocera Inferiore (SA), Italy. Nicola Franza, Owner | 3480562144 | info@dosimetrica.com
About Medscint Medscint is a Canadian-based company that partners with the experts in the field to push the limits of innovation in radiotherapy. They aim at facilitating the work of medical physicists and researchers worldwide with their versatile, cutting-edge optics and photonics technology. For more information, visit www.medscint.com. Media Contact: Medscint Inc. 1405, Parc Technologique Québec, QC G1l4P5 – CANADA. Jonathan Turcotte, Eng. MBA Co-founder and Chief Marketing Officer | 1-888-901-6521 | info@medscint.com